CASµÇ¼ºÅ | ÖÐÎÄÃû | Ó¢ÎÄÃû | ·Ö×ӽṹʽ | ·Ö×Óʽ | ÏêÇé | ¹©Ó¦ÉÌ |
453562-69-1 | ÄªÌØÈûÄá; N-(2,3-¶þÇâ-3,3-¶þ¼×»ù-1H-ßÅßá-6-»ù)-2-[(4-ßÁ़׻ù)°±»ù]-3-ßÁ़×õ£°· | MoTesanib; N-(2,3-Dihydro-3,3-dimethyl-1H-indol-6-yl)-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide | ![]() | C22H23N5O | ÏêÇé | ¹©Ó¦ÉÌ |
12379-46-3 | 2-¼×»ù¼ºËáÃÌÑÎ; 2-¼×»ù¼ºËáÃÌÑÎ | Magnesium,(2-ethylhexanoato)(quinolinolato)- (8CI); 2-EthylhexoaTesalt of magnesium quinolinolate | ![]() | C17H21MgNO3 | ÏêÇé | ¹©Ó¦ÉÌ |
24358-09-6 | Pentanoic acid,2-(aminocarbonyl)-2-ethyl-3-methyl-, ethyl ester; Malonamicacid, 2-sec-butyl-2-ethyl-, ethyl ester (7CI,8CI); 2-Carbamoyl-2-ethyl-3-methylethyl valerate; BuTesamide | ![]() | C11H21NO3 | ÏêÇé | ¹©Ó¦ÉÌ | |
147816-68-0 | Urs-12-en-28-oic acid,3-[[2-O-(6-deoxy-a-L-mannopyranosyl)-a-L-arabinopyranosyl]oxy]-, (3b)- (9CI); MaTesaponinJ1; Patriniaglycoside A-I | ![]() | C41H66O11 | ÏêÇé | ¹©Ó¦ÉÌ | |
261360-75-2 | (S)-2-AMINOBUT-3-EN-1-OL, BENZOATE SALT; (S)-2-AMINOBUT-3-EN-1-OL, BENZOATE SALT; (S)-2-Aminobut-3-en-1-olbenzoaTesalt(e.e.); (S)-2-AMINOBUT-3-EN-1-OL BENZOATE SALT 95% (98% E.E.) | ![]() | C11H15NO3 | ÏêÇé | ¹©Ó¦ÉÌ | |
143-98-6 | È¥¼×ÓÒÃÀɳ·Ò¾ÆÊ¯ËáÑÎ | DEXTRORPHAN D-TARTRATE; 1,3,4,9,10,10a-hexahydro-11-methyl-2h-10,4a-iminoethanophenanthren-6-oltartr; 17-methyl-,tartrate(1:1)(salt),(+)-morphinan-3-o; d-3-hydroxy-n-methylmorphinantartrate; d-at; dextrophantartrate; DEXTRORPHAN D-TARTRATE ((+)-3-HYDROXY-N- METH; Dextrorphan,TartraTesalt; -Dextrorphan,TartraTesalt | ![]() | C21H29NO7 | ÏêÇé | ¹©Ó¦ÉÌ |
29836-10-0 | 2,3-O-ISOPROPYLIDENE-BETA-D-RIBOFURANOSYLAMINE P-TOLUENESULFONATE SALT; 2,3-O-ISOPROPYLIDENE-BETA-D-RIBOFURANOSYLAMINE P-TOLUENESULFONATE SALT; 2,3-O-isopropylidene-B-D-ribo-*furanosylamine; 2,3-O-Isopropylidene-3-D-ribofuranosylaminep-toluenesulfonaTesalt; 2,3-O-Isopropylidene-b-D-ribofuranosylaminep-toluenesulphonaTesalt; 2,3-o-Isopropylidene-beta-D-ribofuranosylamine | ![]() | C15H23NO7S | ÏêÇé | ¹©Ó¦ÉÌ | |
147385-61-3 | ÁÁëÄËØÈý·ú´×ËáÑÎ | LEUPEPTIN TRIFLUOROACETATE SALT; LEUPEPTIN TRIFLUOROACETATE SALT; ACETYL-LEU-LEU-ARG-AL TRIFLUOROACETATE SALT; LEUPEPTIN TRIFLUOROACETATE FROM*MICROBIA L SOURCE; leupeptintrifluoroacetaTesalt90+%; Leupeptin trifluoroacetate salt,Acetyl-Leu-Leu-Arg-al trifluoroacetate salt | ![]() | C22H39F3N6O6 | ÏêÇé | ¹©Ó¦ÉÌ |
17238-55-0 | Âðßø-4-¼×ëß°ëÁòËáÑÎ | MORPHOLINE-4-CARBOXAMIDINE HEMISULFATE; 4-morpholinecarboxamidine,sulfate(2:1); 4-morpholinecarboximidamide,sulfate(2:1); n¡¯,n¡¯-anhydrobis(beta-hydroxyethyl)guanidinesulfate; MORPHOLINE-4-CARBOXAMIDINE HEMISULFATE; MORPHOLINE-4-CARBOXAMIDINEHEMISULFATesaLT; 4-Morpholinecarboxamidine sulfate ,95%; Morpholine-4-carboxamidine hemisulfate ,97% | ![]() | C10H24N6O6S | ÏêÇé | ¹©Ó¦ÉÌ |
68935-27-3 | (+)-Ñ̼î¶þ¶Ô¼×±½¼×õ£»ù¾ÆÊ¯ËáÑÎ | (+)-NICOTINE (+)-DI-P-TOLUOYLTARTRATE SALT; R(+)-3-(1-METHYL-2-PYRROLIDINYL)PYRIDINIUM (+)-DI-P-TOLUOYL TARTRATE; (+)-NICOTINE DI-P-TOLUOYL-D-TARTRATE SALT; (+)-NICOTINE (+)-DI-P-TOLUOYLTARTRATE SALT; (+)-nicotine (+)-di-P-toluoyltartrate; Di-p-Toluoyl-D-tartraTesalt; S(-)-3-(1-Methyl-2-pyrrolidinyl)pyridinium (+)-di-p-toluoyl tartrate; (+)-Nicotine (+)-di-p-toluoyltartrate salt; (+)-Di-p-toluoyltartrate salt | ![]() | C30H32N2O8 | ÏêÇé | ¹©Ó¦ÉÌ |
923288-90-8 | Nilotinib hcl monohydrate; Nilotinib hcl monohydrate; NilotinibhydrochloridemonohydraTesalt | ÎÞ | ÏêÇé | ¹©Ó¦ÉÌ | ||
86562-85-8 | S-ÏÙÜÕL-µ°°±Ëá ¶Ô¼×±½»ÇËáÑÎ | S-ADENOSYL-L-METHIONINE P-TOLUENESULFONATE SALT; ADENOSYL-L-METHIONINE, S-P-TOLUENESULFONATE; SAM-E P-TOLUENESULFONATE; S-ADENOSYL METHIONINE P-TOLUENESULFONATE; S-ADENOSYL-L-METHIONINE P-TOLUENESULFONATE SALT; S-adenosyl-L-methionine*P-toluenesulfonate; SAMe-p-toluenesulfonaTesalt; ADEMETHIONINEP-TOLUENESULFONATE; 5'[(3-Amino-3-carboxypropyl)methylsulfonio]-5'deoxyadenosine sulfate-p-toluenesulfonate | ![]() | C22H32N6O8S2 | ÏêÇé | ¹©Ó¦ÉÌ |